Results 211 to 220 of about 278,243 (313)

A nomogram model based on dual-center data predicts lymph node metastasis in endometrial cancer. [PDF]

Discov Oncol
Junling L, Jiming C, Wenjie W, Yafeng Z, Fang L.   +4 more
europepmc   +1 more source

Peritumoral habitat radiomics predicts axillary lymph node metastasis in breast cancer. [PDF]

iScience
Ding J, Qiu Z, Peng H, Chen S, Zhong Q, Zhang Y, Yang Z, Huang Z.   +7 more
europepmc   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Advanced Ovarian Dysgerminoma With Supraclavicular Lymph Node Metastasis and Peritoneal Carcinomatosis: A Rare Case Report. [PDF]

Clin Case Rep
Khaniya B, Shah S, Adhikari D, Acharya A, Poudel A, Gautam S.   +5 more
europepmc   +1 more source

Integrated spherical nucleic acid nanoreactor mobilizes targeted PD‐L1 proteolysis and cuproptosis for robust breast cancer immunotherapy

BMEMat, EarlyView.
This study provides an integrated spherical nucleic acid nanoreactor (denoted as AMCuD) for targeted PD‐L1 degradation and chemo‐dynamically enhanced cuproptosis to synergically elicit robust immunotherapy against the triple‐negative breast cancer (TNBC) growth, recurrence and metastasis.
Ningxi Li, Honglin Huang, Qianyi Zeng, Li Zeng, Ziman Yang, Jinyang Shen, Shun Li, Hong Yang, Yiyao Liu, Chunhui Wu   +9 more
wiley   +1 more source

MGST1 drives lymph node metastasis in papillary thyroid carcinoma via mitochondrial metabolic reprogramming and immune suppression. [PDF]

Front Immunol
Wang QX, Yu CF, Zhang KC, Zhang JH, Zhou XJ, Zou TX, Huang HZ, Han TY, Mei HZ, Su KB, You J, Qu JM, Xie C, Li Q, Cai YF.   +14 more
europepmc   +1 more source

Carbon Dots for Cancer Theranostics: Synthesis Strategies, Luminescence Properties, and Advances in Bioimaging‐Guided Diagnosis and Therapy

Chemistry – A European Journal, EarlyView.
Lighting up the path to precision oncology: This review comprehensively summarizes the rational design of carbon dots (CDs), elucidating how core size, surface chemistry, and heteroatom doping dictate their luminescence mechanisms. Special emphasis is placed on engineering NIR‐II emissive CDs for deep‐tissue imaging.
Zekun Yan, Yupeng Liu, Jinyun Tan, Songnan Qu   +3 more
wiley   +1 more source

Primary CD5-negative intrathyroidal thymic carcinoma with neuroendocrine differentiation and lymph node metastasis acquiring CD5 expression:case report. [PDF]

Braz J Otorhinolaryngol
Wen L, Zhou L, Wang M, Ma G, Hong W.
europepmc   +1 more source

From Metabolic Crisis to Molecular Classification: Multidisciplinary Management of Synchronous Endometrioid Ovarian and Endometrial Carcinomas With Massive Tumor Burden

Cancer Nexus, EarlyView.
Managing massive tumor burden in synchronous endometrioid carcinomas. The graphical abstract summarizes the clinical pathway from presentation with massive ascites, pleural effusion, and critical metabolic abnormalities to multidisciplinary stabilization, surgical management, integrated morphologic–molecular classification, and shared decision‐making ...
Anna Homeniuk, Leena Abdalla, Sharon Fitzgerald   +2 more
wiley   +1 more source

PDE4C stabilized by ELAVL1 promotes lymph node metastasis in papillary thyroid cancer. [PDF]

Am J Cancer Res
Cui T, Zhang Y, Li W, Zhang D, Liu W, Gong H.   +5 more
europepmc   +1 more source